Diabetic autonomic neuropathy: The clinical interpretation of improved technology

Diabetes Technology and Therapeutics

Volumn 3, Issue 1, 2001, Pages 77-79

  Aronson, D ^a   Burger, A J ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIABETIC NEUROPATHY; DISEASE COURSE; HEART RATE VARIABILITY; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 0035041642     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091501750220037     Document Type: Conference Paper

References (29)

1. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy
2. Neuropathy profile of diabetic patients in a pancreas transplantation program
3. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis
4. Diabetic autonomic neuropathy
5. Cardiac denervation in diabetic neuropathy
6. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes
7. Mortality in diabetic patients with cardiovascular autonomic neuropathy
8. The natural history of diabetic autonomic neuropathy
9. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus
10. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients
11. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease
12. Silent myocardial ischemia: Role of subclinical neuropathy in patients with and without diabetes
13. Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment
14. Diagnosis and management of diabetic autonomic neuropathy
15. Heart-rate variability and cardiac autonomic function in diabetes
16. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy
17. Heart rate variability measurement in diabetic neuropathy: Review of methods
18. Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics
19. Heritability of heart rate variability: The Framingham Heart Study
20. Ambient pollution and heart rate variability
21. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms
22. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure
23. Heart rate variability in obesity and the effect of weight loss
24. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: Evidence for possible early autonomic dysfunction in insulin-resistant subjects
25. Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease
26. Heart rate variability: Standards of measurement physiological interpretation clinical use
27. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy
28. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie
29. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study